Radius Health (DE:1R8)

Radius Health Stock Price & Analysis


1R8 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€4.97 - €23.00
Previous Close€9.72
Average Volume (3M)741.00
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$71.61M
Total Debt (Recent Filing)$223.29M
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares Outstanding47,600,500
Standard Deviation0.20
10 Day Avg. Volume0
30 Day Avg. Volume741
Price to Book (P/B)-1.80
Price to Sales (P/S)3.75
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-16.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside― Upside
Rating ConsensusHold
Number of Analyst Covering5



What was Radius Health’s price range in the past 12 months?
Radius Health lowest stock price was €4.97 and its highest was €23.00 in the past 12 months.
    What is Radius Health’s market cap?
    Currently, no data Available
    When is Radius Health’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Radius Health’s earnings last quarter?
    Currently, no data Available
    Is Radius Health overvalued?
    According to Wall Street analysts Radius Health’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
      Does Radius Health pay dividends?
      Radius Health does not currently pay dividends.
      What is Radius Health’s EPS estimate?
      Radius Health’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Radius Health have?
      Currently, no data Available
      What happened to Radius Health’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Radius Health?
      Among the largest hedge funds holding Radius Health’s share is Farallon Capital Management, L.L.C.. It holds Radius Health’s shares valued at 22M.


        Radius Health Stock Smart Score

        The Radius Health Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
        Learn more about TipRanks Smart Score

        Company Description

        Radius Health

        Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company's lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes abaloparatide transdermal patch for potential use in osteoporosis and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Waltham, MA.


        Forecast EPS vs Actual EPS

        Currently, no data available
        Please return soon. This page is being updated.

        Similar Stocks
        Price & Change
        Gilead Sciences
        Vertex Pharmaceuticals

        Popular Stocks

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis